• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SLIT 通过恢复 Tr1 和单核细胞产生的 IL-10 来改善雪松花粉过敏∼IL-10 产生能力对于变应性至关重要∼。

SLIT improves cedar pollinosis by restoring IL-10 production from Tr1 and Monocytes∼IL-10 productivity is critical for becoming allergic∼.

机构信息

Department of Dermatology, Mie University Graduate School of Medicine, Japan.

出版信息

Allergol Int. 2011 Mar;60(1):45-51. doi: 10.2332/allergolint.10-OA-0198. Epub 2010 Nov 24.

DOI:10.2332/allergolint.10-OA-0198
PMID:21099249
Abstract

BACKGROUND

Allergen-specific immunotherapy (SIT) is currently used for several allergic disorders and IL-10-producing regulatory T cells (Tr1) induced by SIT suppress allergic reactions. We investigated the relation between IL-10 production and acquiring allergy.

METHODS

A prospective study was undertaken to evaluate the effect of SIT on IL-10 production in T cells and other cell fractions in children with pollinosis. In addition, blood samples were collected from non-allergic healthy controls and patients with pollinosis to compare the levels of IL-10 production. PBMC were cultured with pollen peptides or control allergens, and the IL-10 production from monocyte and CD4 T cell was analyzed.

RESULTS

Monocytes and CD4 T cells from SIT group of patients produced high levels of IL-10, suggesting that the induction of IL-10 is essential for inducing T cell tolerance. IL-10 production from monocytes and T cells was significantly increased in non-allergic controls compared to patients with pollinosis. This high IL-10 production was observed even when PBMC were stimulated with antigens other than pollen peptides.

CONCLUSIONS

IL-10 is critical for induction of specific T cell tolerance, and increased production of IL-10 by monocytes and T cells during inflammatory responses or after SIT may influence effector cells in allergy. Present data implicates that the low productivity of IL-10 by monocytes and T cells is closely related with sensitivity to multiple allergens, and resistance to allergic diseases. Augmentation of constitutive IL-10 production from immune system is a potential therapeutic approach for allergic disorders.

摘要

背景

变应原特异性免疫疗法(SIT)目前用于多种过敏性疾病,SIT 诱导的 IL-10 产生的调节性 T 细胞(Tr1)可抑制过敏反应。我们研究了 SIT 诱导的 IL-10 产生与获得过敏之间的关系。

方法

进行了一项前瞻性研究,以评估 SIT 对花粉症儿童 T 细胞和其他细胞群中 IL-10 产生的影响。此外,还从非过敏性健康对照者和花粉症患者中采集血样,以比较 IL-10 产生水平。用花粉肽或对照变应原培养 PBMC,并分析单核细胞和 CD4 T 细胞的 IL-10 产生。

结果

来自 SIT 组患者的单核细胞和 CD4 T 细胞产生高水平的 IL-10,表明 IL-10 的诱导对于诱导 T 细胞耐受至关重要。与花粉症患者相比,非过敏性对照者的单核细胞和 T 细胞产生的 IL-10 明显增加。即使在用抗原而非花粉肽刺激 PBMC 时,也观察到这种高 IL-10 产生。

结论

IL-10 对于诱导特异性 T 细胞耐受至关重要,在炎症反应或 SIT 后,单核细胞和 T 细胞中 IL-10 的产生增加可能会影响过敏中的效应细胞。目前的数据表明,单核细胞和 T 细胞中 IL-10 的低产量与对多种变应原的敏感性以及对过敏性疾病的抵抗力密切相关。增强免疫系统中 IL-10 的组成性产生可能是治疗过敏疾病的一种潜在治疗方法。

相似文献

1
SLIT improves cedar pollinosis by restoring IL-10 production from Tr1 and Monocytes∼IL-10 productivity is critical for becoming allergic∼.SLIT 通过恢复 Tr1 和单核细胞产生的 IL-10 来改善雪松花粉过敏∼IL-10 产生能力对于变应性至关重要∼。
Allergol Int. 2011 Mar;60(1):45-51. doi: 10.2332/allergolint.10-OA-0198. Epub 2010 Nov 24.
2
Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.桦树花粉免疫治疗导致调节性 T 细胞的差异诱导和辅助性 T 细胞免疫偏离的延迟。
J Immunol. 2010 Feb 15;184(4):2194-203. doi: 10.4049/jimmunol.0901379. Epub 2010 Jan 4.
3
Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.对日本柳杉花粉致敏的无症状受试者进行预防性舌下免疫治疗的免疫学参数
Allergol Int. 2015 Jan;64(1):54-9. doi: 10.1016/j.alit.2014.07.001. Epub 2014 Oct 20.
4
Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis.变应原特异性免疫疗法可改变变应性鼻炎中一种共抑制分子——B和T淋巴细胞衰减器的表达。
Clin Exp Allergy. 2008 Dec;38(12):1891-900. doi: 10.1111/j.1365-2222.2008.03116.x. Epub 2008 Oct 30.
5
Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy.经过 1 年的变应原特异性免疫治疗后,IL-10 分泌型 I 型 T 调节细胞的频率和功能增强。
Int Arch Allergy Immunol. 2012;159(4):391-8. doi: 10.1159/000338995. Epub 2012 Jul 26.
6
Induction of IL-10-producing regulatory T cells with TCR diversity by epitope-specific immunotherapy in pollinosis.在花粉症中通过表位特异性免疫疗法诱导具有TCR多样性的产生白细胞介素-10的调节性T细胞
J Allergy Clin Immunol. 2009 Oct;124(4):842-5.e7. doi: 10.1016/j.jaci.2009.06.020. Epub 2009 Aug 22.
7
Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.草单体制剂舌下免疫疗法对变应原特异性T细胞增殖及白细胞介素10产生的影响。
Ann Allergy Asthma Immunol. 2008 Apr;100(4):343-50. doi: 10.1016/S1081-1206(10)60597-2.
8
Antigen-specific immunotherapy against allergic rhinitis: the state of the art.变应性鼻炎的抗原特异性免疫治疗:最新进展。
Allergol Int. 2010 Mar;59(1):21-31. doi: 10.2332/allergolint.09-RAI-0151. Epub 2010 Feb 25.
9
Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.儿童舌下免疫疗法可调节变应原诱导的外周血单个核细胞中细胞因子mRNA的体外表达。
Allergy. 2006 Oct;61(10):1184-90. doi: 10.1111/j.1398-9995.2006.01206.x.
10
The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects.T 细胞对主要草过敏原的反应受到调节,包括在特应性而非非特应性受试者中产生 IL-10。
Int Arch Allergy Immunol. 2010;152(3):243-54. doi: 10.1159/000283033. Epub 2010 Feb 11.

引用本文的文献

1
Effect of heat-killed KW3110 on mild to moderate seasonal allergic rhinitis symptoms in Japanese adults: a randomized, double-blind, placebo-controlled parallel-group study.热灭活KW3110对日本成年人轻至中度季节性变应性鼻炎症状的影响:一项随机、双盲、安慰剂对照平行组研究。
Front Nutr. 2025 Jun 25;12:1568329. doi: 10.3389/fnut.2025.1568329. eCollection 2025.
2
Potential Effects of AIT on Nonspecific Allergic Immune Responses or Symptoms.变应原免疫治疗对非特异性过敏免疫反应或症状的潜在影响。
J Clin Med. 2023 May 31;12(11):3776. doi: 10.3390/jcm12113776.
3
Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy.
1型调节性T(Tr1)细胞在变应原特异性免疫治疗中的作用。
Front Allergy. 2022 Aug 3;3:981126. doi: 10.3389/falgy.2022.981126. eCollection 2022.
4
The impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitis.变应原暴露及特异性免疫疗法对变应性鼻炎循环血细胞的影响
World Allergy Organ J. 2018 Aug 15;11(1):19. doi: 10.1186/s40413-018-0197-0. eCollection 2018.
5
Next generation immunotherapy for tree pollen allergies.下一代针对树花粉过敏的免疫疗法。
Hum Vaccin Immunother. 2017 Oct 3;13(10):2402-2415. doi: 10.1080/21645515.2017.1367882.
6
FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy.FoxP3+Tregs 对舌下变应原特异性免疫治疗儿童的反应取决于过敏的表现。
J Immunol Res. 2015;2015:731381. doi: 10.1155/2015/731381. Epub 2015 Sep 20.